Market Tracker

07/28 4:27am ET

TG Therapeutics Inc (NASDAQ:TGTX)

11.55
Delayed Data
As of Jul 27
 -0.25 / -2.12%
Today’s Change
4.10
Today|||52-Week Range
15.35
+148.39%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close11.80
Today’s open11.90
Day’s range11.38 - 12.13
Volume1,237,838
Average volume (3 months)1,607,860
Market cap$787.9M
Dividend yield--
Data as of 07/27/2017

Growth & Valuation

Earnings growth (last year)-15.94%
Earnings growth (this year)-13.12%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,496.53
Price/Book18.68

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...-0.46-1.55%
FLXNFlexion Therapeutics...-0.71-2.89%
LCILannett Company Inc-0.25-1.20%
KERXKeryx Biopharmaceuti...-0.37-4.98%
Data as of 07/27/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$152.4K
Annual profit (last year)-$78.3M
Net profit margin-51,353.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
Chief Financial Officer, Secretary &
Treasurer
Sean A. Power
Corporate headquarters
New York, New York

Forecasts